MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
470.27%
Quick Ratio
470.27%
Cash Ratio
271.28%
Debt to Asset Ratio
22.94%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
92,687
177,913
85,412
90,140
Marketable securities
63,580
22,472
51,440
85,295
Prepaid expenses and other current assets
4,405
4,592
5,170
7,788
Total current assets
160,672
204,977
142,022
183,223
Fixed assets, gross
2,658
2,515
2,515
2,515
Less accumulated depreciation
2,019
1,957
1,893
1,806
Property and equipment, net
639
558
622
709
Operating lease right-of-use assets
3,055
1,866
2,069
2,270
Restricted cash
456
606
606
606
Other assets
480
504
523
542
Total assets
165,302
208,511
145,842
187,350
Accounts payable
7,597
8,576
5,216
11,100
Accrued expenses
25,367
38,123
58,474
32,865
Operating lease liabilities, current
1,202
1,058
1,105
1,151
Total current liabilities
34,166
47,757
64,795
45,116
Operating lease liabilities
3,754
2,721
2,962
3,196
Total liabilities
37,920
50,478
67,757
48,312
Preferred stock 0.001 par value per share 5,000,000 shares authorized as of june 30, 2026 and december 31, 2025 500,000 and 250,000 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
1
1
-
-
Common stock, 0.001 par value per share 137,016,100 and 115,000,000 shares authorized as of june 30, 2026 and december 31, 2025, respectively 103,882,937 and 83,090,392 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
103
103
83
86
Additional paid-in capital
624,516
622,367
512,779
511,219
Accumulated deficit
-497,226
-464,444
-434,831
-372,333
Accumulated other comprehensive gain (loss)
-12
6
54
66
Total stockholders equity
127,382
158,033
78,085
139,038
Total liabilities and stockholders equity
165,302
208,511
145,842
187,350
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$92,687K (350.22%↑ Y/Y)Marketable securities$63,580K (-46.09%↓ Y/Y)Prepaid expenses andother current assets$4,405K (-37.36%↓ Y/Y)Fixed assets, gross$2,658K (5.69%↑ Y/Y)Total current assets$160,672K (10.39%↑ Y/Y)Operating leaseright-of-use assets$3,055K (23.78%↑ Y/Y)Property and equipment,net$639K (-19.82%↓ Y/Y)Other assets$480K (-14.44%↓ Y/Y)Restricted cash$456K (-24.75%↓ Y/Y)Less accumulateddepreciation$2,019K (17.52%↑ Y/Y)Total assets$165,302K (10.21%↑ Y/Y)Total liabilities andstockholders equity$165,302K (10.21%↑ Y/Y)Total stockholdersequity$127,382K (6.28%↑ Y/Y)Total liabilities$37,920K (25.84%↑ Y/Y)Accumulated deficit-$497,226K (-53.17%↓ Y/Y)Accumulated othercomprehensive gain (loss)-$12K (-33.33%↓ Y/Y)Additional paid-in capital$624,516K (40.52%↑ Y/Y)Total currentliabilities$34,166K (28.21%↑ Y/Y)Operating leaseliabilities$3,754K (7.72%↑ Y/Y)Common stock, 0.001 parvalue per share...$103K (60.94%↑ Y/Y)Preferred stock 0.001 parvalue per share...$1K Accrued expenses$25,367K (18.81%↑ Y/Y)Accounts payable$7,597K (82.23%↑ Y/Y)Operating leaseliabilities, current$1,202K (6.47%↑ Y/Y)

Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics, Inc. (LRMR)